Stocks-IDXX-IDEXX Laboratories Inc

IDXX IDEXX Laboratories Inc

458.11 -0.18 (-0.04%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: IDEXX Laboratories Inc's revenues increased by 4.73% and amounted to 3.37B. Net income decreased by 8.83% to 679.09M. Net assets decreased by 11.78% to 608.74M and EPS decreased from 8.60 to 8.03.
IDXX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
59.46%
Net Profit Margin
19.93%
Operating Margin
29.31%
Return On Investment
48.49%